N-[4-(5-{1-[(4-cyanophenyl)methyl]pyrrolidin-2-yl}-1,2,4-oxadiazol-3-yl)pyridin-2-yl]methanesulfonamide



Compound IDCDAMM00176
Common nameN-[4-(5-{1-[(4-cyanophenyl)methyl]pyrrolidin-2-yl}-1,2,4-oxadiazol-3-yl)pyridin-2-yl]methanesulfonamide
IUPAC nameN-[4-[5-[1-[(4-cyanophenyl)methyl]pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl]pyridin-2-yl]methanesulfonamide
Molecular formulaC20H20N6O3S

Experimental data

Retention time59.05
Adduct[M+H]+
Actual mz425.139
Theoretical mz425.139
Error0.39
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score4.7578

Identifiers and class information

Inchi keyQGYGAZBGUQXSJG-UHFFFAOYSA-N
SmilesCS(=O)(=O)NC1=NC=CC(=C1)C2=NOC(=N2)C3CCCN3CC4=CC=C(C=C4)C#N
SuperclassBenzenoids
ClassBenzene and substituted derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)424.476
Computed dipole moment(dipole)11.181
Total solvent accessible surface area (SASA)755.637
Hydrophobic component of SASA (FOSA)255.014
Hydrophilic component of SASA (FISA)216.702
Pie component of the SASA (PISA)283.881
Weakly polar component of the SASA (WPSA)0.04
Total solvent accesible volume (volume)1312.39
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)12
Free energy of solvation of dipole (dip^2/V)0.0952516
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0158806
Globularity descriptor (glob)0.767174
Predicted polarizability in cubic angstroms (QPpolrz)45.868
Predicted hexadecane/gas partition coefficient (QPlogPC16)14.341
Predicted octanol/gas partition coefficient (QPlogPoct)24.734
Predicted water/gas partition coefficient (QPlogPw)17.124
Predicted octanol/water partition coefficient (QPlogPo/w)0.723
Predicted aqueous solubility (QPlogS)-4.406
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.021
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.379
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)21.768
Predicted brain/blood partition coefficient (QPlogBB)-1.794
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)8.746
Predicted skin permeability, log Kp (QPlogKp)-6.096
PM3 calculated ionization potential (IP(ev))9.659
PM3 calculated electron affinity (EA(eV))1.287
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-0.49
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)55.126
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)129.455
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9Y5N1HRH3Histamine H3 receptorT64765SEA
P41594GRM5Metabotropic glutamate receptor 5T99347SEA
P42785PRCPLysosomal Pro-X carboxypeptidaseT20371SEA
Q8TDU6GPBAR1G-protein coupled bile acid receptor 1T86273SEA
P49327FASNFatty acid synthaseT16514SEA
P41743PRKCIProtein kinase C iotaT83174SEA
Q9NRA0SPHK2Sphingosine kinase 2T31989SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T64765DI0392Somnolence[ICD-11: MG42]Q9Y5N1HRH3
T99347DI0152Fragile X chromosome[ICD-11: LD55]P41594GRM5
T99347DI0331Parkinsonism[ICD-11: 8A00]P41594GRM5
T86273DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q8TDU6GPBAR1
T16514DI0096concerning food/fluid intake symptom[ICD-11: MG43]P49327FASN
T83174DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P41743PRKCI
T31989DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9NRA0SPHK2

Copyright © 2025